Coronary Artery Disease — Cost-effectiveness of EGDT Using FloTrac/EV1000
Citation(s)
Cost-effectiveness of Applying Early Goal-directed Therapy Using FloTrac/EV1000 Platform in Patients Undergoing Coronary Artery Bypass Graft With Cardiopulmonary Bypass